MAPK3 and pulmonary fibrosis: Dysregulation of this balance is implicated in various diseases, including cancer and idiopathic pulmonary fibrosis [29, 30], where overexpression of Dusp1 can lead to decreased Erk1/2 activity and hinder tumor cell and pulmonary fibroblasts proliferation.